Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)
China · Delayed Price · Currency is CNY 3.280
-0.060 (-1.80%)
May 20, 2026, 12:04 PM CST
Tianjin Chase Sun Pharmaceutical Co.,Ltd Company Description
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research, development, production, and marketing of various pharmaceutical products in China.
The company offers Chinese herb preparation products, medicinal granules, synthetic drugs, biotech drugs, medical apparatus, and Internet based therapy.
It is also involved in the research and development of various drugs in the areas of sepsis, pulmonary hypertension, leukemia, cardiovascular and cerebrovascular diseases, arthritis, ischemic stroke, HCV, vascular disease, psychosis, and chemotherapy, as well as anesthesia drugs and immunomodulators.
The company was founded in 1996 and is based in Tianjin, China.
Tianjin Chase Sun Pharmaceutical Co.,Ltd
| Country | China |
| Founded | 1996 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 4,852 |
| CEO | Wu Jun Lan |
Contact Details
Address: Building B01, Entrepreneurial Headquarters Base Tianjin China | |
| Phone | 86 22 5962 3160 |
Stock Details
| Ticker Symbol | 300026 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000GF1 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Wu Jun Lan | Vice Chairman and GM |
| Wu Sun | Executive Vice President, Chief Financial Officer, Chief Accountant and Director |
| Rui Qiang Chen | Deputy General Manager |
| Chun Xu Li | Deputy GM and Director |
| Yi Yang | Secretary of the Board of Directors |
| Kun Zhang | Deputy General Manager |
| Xiao Zhong Lu | Deputy General Manager |